This inventor holds 2 USPTO granted patents. Top assignee: Kancera Ab. Active years: 2017-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2018
Title: Mattias Joensson: Innovator in Pharmaceutical Chemistry
Introduction
Mattias Joensson is a notable inventor based in Knivsta, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target inflammation and cancer. With a total of 2 patents, his work is paving the way for new therapeutic options.
Latest Patents
Joensson's latest patents include bisarylsulfonamides that are useful in the treatment of inflammation and cancer. The first patent describes a compound of formula (I) that is effective for treating cancer, inflammation, and inflammatory disorders, along with a pharmaceutical composition containing this compound. The second patent reiterates the same compound and its applications, emphasizing its potential in medical treatments.
Career Highlights
Mattias Joensson is currently associated with Kancera AB, a company focused on developing innovative treatments for serious diseases. His work at Kancera has been instrumental in advancing research and development in the pharmaceutical sector.
Collaborations
Some of his notable coworkers include Jessica Martinsson and Katarina Faernegardh, who contribute to the collaborative efforts at Kancera AB.
Conclusion
Mattias Joensson's innovative work in pharmaceutical chemistry highlights his commitment to addressing critical health issues. His patents reflect a promising future for treatments targeting inflammation and cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile